BioNTech SE

Forecast & Rating20 analysts currently cover BioNTech SE, with about 70.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $118.94, about 23.0% upside from the current price of $96.69. Price targets range from $75.59 to $144.22 — a wide spread, showing clear disagreement over just how much BioNTech SE can rise. Historically, about 42.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study BioNTech SE closely still see room for the stock to rise. Data as of Sep 15, 2026; for reference only and not investment advice.